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Dr Anthony L. Estrera (Houston, Tex). Very nice and clear
presentation, Len.
The ACC and AHA have provided us with guidelines for
invasive testing for CAD before noncardiac major vascular
surgery based primarily on clinical status; that is, the presence
of symptoms and the functional status, as represented bymetabolic
equivalents or METS, and have recommended coronary artery
intervention for patients with a reduced ejection fraction and
multivessel disease and those with left main disease.
This was based on level 1 data from randomized trials, as you
had mentioned, on major vascular surgery, albeit, few or no
patients were included with TAAAs.
Dr Girardi has adopted a policy to perform cardiac
catheterization for most of these patients before TAAA repair,
and that 1- or 2-vessel disease, if discovered, should receive
intervention with PCI using a bare metal stent.
You demonstrated excellent results in this group of 44 patients,
with no postoperative MI, no stent thrombosis, no bleeding, and no
death. However, I am still concerned about opposing the guidelines
of the AHA and ACC.
I have 2 questions. First, as suggested in your protocol, most
patients underwent cardiac catheterization before TAAA repair.
With concern for postoperative renal failure, although you had a
low percentage of it, what was the interval between heart
catheterization and repair, and what is your current policy
regarding this?
Dr Girardi. In the patients who are coming in for elective
repair, just as for any other aneurysm repair, we will perform
catheterization the day before. However, we ask for only a
coronary angiogram and a right heart catheterization. We do not
perform a formal aortogram or a V-gram. We try to keep the
contrast to a minimum, and we have not found that to be a problem
contributing to renal failure postoperatively.
Thus, in most of the patients, we will perform catheterization
the day before just as if they were going to undergo valve surgery
or coronary bypass.
Dr Estrera. Second question. In a report from our group, we
suggested that patients with normal functional capacity and a
normal left ventricular ejection fraction did not require additional
workup, just as has been suggested by the ACC and AHA. In your
study, 82% of the study cohort were asymptomatic and would not
have normally undergone an invasive evaluation.168 The Journal of Thoracic and Cardiovascular SurgWithout a true control group, how do you really know that these
patients would not have done well without PCI, and should this
have tempered your conclusions?
Dr Girardi. Well, certainly I think 1 of the reasons that we
started studying this was exactly as you had stated, our
concern for actually going against the recommendations of the
AHA/ACC guidelines.
Now, the IIIb recommendations are pretty strong, especially
when they start talking about the potential harm associated with
the procedure or with PCI itself. We wanted to ensure that, at
the very minimum, we were not hurting anybody, and I think we
have shown that we have not. We have not hurt these patients
with the procedure itself. We also have not hurt them with
complications from the stenting.
The only point that we can use to state that we are really
providing patients with a benefit is when you consider the
historical controls of TA repair, and the incidence of MI, although
not crazy, is still pretty high, 5% or 6%. Also, if the patients
develop these complications, it has been a strong predictor for a
bad outcome. For those patients who we took to the operating
room emergently who did experience a MI, the MIs were almost
all uniformly fatal.
The stresses of TA repair as far as the hemodynamics, as far as
the cardiac work and the amount of ischemia generated is far
different than what we will see in patients undergoing peripheral
vascular surgery, from whom most of these data were generated.
Thus, we think it is justified. Certainly, if we can do better at
protecting them from a potentially fatal complication such as
MI, we think it is worthwhile.
Dr Estrera. Nice job, Len.
DrMarcR.Moon (St Louis, Mo). It was not clear to me, but did
you have any functional analysis that could have, potentially—for
example, stress tests—that could have ruled out most of the
patients so that you did not have to perform catheterization on
everybody?
Dr Girardi.We did not perform stress tests for all the patients.
We were very aggressive with catheterization.
One of the concerns in that situation is the patients who have left
main disease, which constituted about 7% of the patients who
eventually underwent CABG. Most of those were patients with
left main disease. As you know, the stress test often will not detect
left main disease because of balanced ischemia.
We have been relying less on nuclear stress imaging and more
on computed tomographic angiography currently to study the
coronary arteries. In those patients for whom we have a low index
of suspicion for CAD, we have mostly used cardiac computed
tomographic angiography rather than even performing a stress test.
Dr Moon. That is 1 approach. We do perform stress tests for
everybody, using an adenosine thallium nuclear test or dobutamine
echocardiography. If those tests have negative findings, we do not
perform catheterization. However, that is a different approach.ery c January 2014
